Evidence map›Paper›PMID 30792655›Full record

ArticleFrontiers in pharmacology2019

Antibacterial Activity of

Nicholas Richwagen, James T Lyles, Brandon L F Dale, Cassandra L Quave

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 50 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Biological Activities and Chemical Profiles ofPlants (Basel, Switzerland) · 2023
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nicholas RichwagenCenter for the Study of Human Health, Emory College of Arts and Sciences, Atlanta, GA, United States.
James T LylesCenter for the Study of Human Health, Emory College of Arts and Sciences, Atlanta, GA, United States.
Brandon L F DaleDepartment of Dermatology, Emory University School of Medicine, Atlanta, GA, United States.
Cassandra L QuaveCenter for the Study of Human Health, Emory College of Arts and Sciences, Atlanta, GA, United States.
Emory and Henry College · USEmory University · US

Funding

Novel compounds from botanical innovation yields Acinetobacter treatmentsR21AI136563 · NIAID · EMORY UNIVERSITY · PI QUAVE, CASSANDRA LEAH · 2018 to 2019
$443k
NIAID NIH HHS R21 AI136563
6 · The paper itself

Abstract

Plants in the genus

Indexed as

antibiotic resistanceCrassulaceaemedicinal plantsMICphytochemicals

Identifiers

PMID30792655
PMCPMC6374630
OpenAlexW2913198060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.